Cargando…

Effects of (−)‐MBP, a novel 5‐HT(2C) agonist and 5‐HT(2A/2B) antagonist/inverse agonist on brain activity: A phMRI study on awake mice

A novel serotonin ligand (−)‐MBP was developed for the treatment of schizophrenia that has 5‐HT(2A/2B) antagonist activity together with 5‐HT(2C) agonist activity. The multi‐functional activity of this novel drug candidate was characterized using pharmacological magnetic resonance imaging. It was hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sathe, Preeti K., Ramdasi, Gargi R., Giammatteo, Kaylie, Beauzile, Harvens, Wang, Shuyue, Zhang, Heng, Kulkarni, Praveen, Booth, Raymond G., Ferris, Craig F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576165/ https://www.ncbi.nlm.nih.gov/pubmed/37837184 http://dx.doi.org/10.1002/prp2.1144

Ejemplares similares

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study
por: Altabella, Luisa, et al.
Publicado: (2014)

Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists
por: Avdonin, Pavel V., et al.
Publicado: (2019)

5-HT(2A) Agonists: A Novel Therapy for Functional Neurological Disorders?
por: Bryson, Alexander, et al.
Publicado: (2017)

Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT(2C) Agonists
por: Kim, Juhyeon, et al.
Publicado: (2019)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

Altered 5-HT(2C )receptor agonist-induced responses and 5-HT(2C )receptor RNA editing in the amygdala of serotonin transporter knockout mice
por: Moya, Pablo R, et al.
Publicado: (2011)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
por: Peng, Liang, et al.
Publicado: (2014)

5-HT(2) and 5-HT(7) receptor agonists facilitate plantar stepping in chronic spinal rats through actions on different populations of spinal neurons
por: Sławińska, Urszula, et al.
Publicado: (2014)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis
por: Heekeren, Karsten, et al.
Publicado: (2008)

Investigating interactions between phentermine, dexfenfluramine, and 5-HT(2C) agonists, on food intake in the rat
por: Grottick, Andrew J., et al.
Publicado: (2014)

Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT(2C) Receptor
por: Veeramachaneni, Ganesh Kumar, et al.
Publicado: (2019)

5-HT(2C) Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
por: Przegaliński, Edmund, et al.
Publicado: (2023)

Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT(2A) and 5-HT(2B) receptors in chondrocytes
por: Hori, Ayaka, et al.
Publicado: (2017)

Review: 5-HT(1), 5-HT(2), 5-HT(3) and 5-HT(7) Receptors and their Role in the Modulation of Pain Response in the Central Nervous System
por: Cortes-Altamirano, Jose Luis, et al.
Publicado: (2018)

SB 206553, a putative 5-HT(2C) inverse agonist, attenuates methamphetamine-seeking in rats
por: Graves, Steven M, et al.
Publicado: (2012)

Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
por: Buchborn, Tobias, et al.
Publicado: (2018)

Evaluation of a 5-HT(2B) receptor agonist in a murine model of amyotrophic lateral sclerosis
por: Arnoux, Alizée, et al.
Publicado: (2021)

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022)

Dose‐dependent effects of esketamine on brain activity in awake mice: A BOLD phMRI study
por: Kawazoe, Kyrsten, et al.
Publicado: (2022)

Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
por: Frangou, Sophia
Publicado: (2016)

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist
por: Clemow, David B., et al.
Publicado: (2020)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Pharmacokinetics of DA-6886, A New 5-HT(4) Receptor Agonist, in Rats
por: Lee, Dae Young, et al.
Publicado: (2022)

Biophysical validation of serotonin 5-HT(2A) and 5-HT(2C) receptor interaction
por: Felsing, Daniel E., et al.
Publicado: (2018)

Effect of the 5-HT(4) receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract
por: Nedi, Teshome, et al.
Publicado: (2018)

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT(2) Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues
por: Nichols, David E., et al.
Publicado: (2014)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders
por: Tack, J, et al.
Publicado: (2012)

Crystal structure of the human 5-HT(1B) serotonin receptor bound to an inverse agonist
por: Yin, Wanchao, et al.
Publicado: (2018)

trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor family
por: Pigott, Adam, et al.
Publicado: (2012)

5-HT(2A), 5-HT(1B/D), 5HT(3) and 5-HT(7) receptors as mediators of serotonin-induced direct contractile response of bovine airway smooth muscle
por: Da Costa Guevara, Darwin, et al.
Publicado: (2021)

Distribution of 5-HT(3), 5-HT(4), and 5-HT(7) Receptors Along the Human Colon
por: Yaakob, Nor S, et al.
Publicado: (2015)

Yokukansan Increases 5-HT(1A) Receptors in the Prefrontal Cortex and Enhances 5-HT(1A) Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice
por: Ueki, Toshiyuki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t0s48q1dprjpfs7vvp0s9qftke